Ultragenyx Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
CEOEmil D. Kakkis
CEOEmil D. Kakkis
Employees1,294
Employees1,294
HeadquartersNovato, California
HeadquartersNovato, California
Founded2010
Founded2010
Employees1,294
Employees1,294
RARE Key Statistics
Market cap3.78B
Market cap3.78B
Price-Earnings ratio-6.79
Price-Earnings ratio-6.79
Dividend yield—
Dividend yield—
Average volume1.09M
Average volume1.09M
High today$39.98
High today$39.98
Low today$39.02
Low today$39.02
Open price$39.57
Open price$39.57
Volume685.20K
Volume685.20K
52 Week high$60.37
52 Week high$60.37
52 Week low$29.59
52 Week low$29.59
RARE News
Simply Wall St 2d
High Growth Tech Stocks In The US Market With Promising PotentialThe U.S. stock market has recently experienced a surge, with the S&P 500 and Nasdaq Composite reaching new all-time highs following a robust June jobs report th...
Simply Wall St 2d
Why Investors Shouldn't Be Surprised By Ultragenyx Pharmaceutical Inc.'s Low P/SYou may think that with a price-to-sales (or "P/S") ratio of 6.3x Ultragenyx Pharmaceutical Inc. ( ) is a stock worth checking out, seeing as almost half of all...
Analyst ratings
95%
of 19 ratingsBuy
94.7%
Hold
5.3%
Sell
0%
People also own
Based on the portfolios of people who own RARE. This list is generated using Robinhood data, and it’s not a recommendation.